Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-16-090881
Filing Date
2016-01-22
Accepted
2016-01-22 06:01:06
Documents
2
Period of Report
2016-01-18
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a16-2714_28ka.htm 8-K/A 20311
2 EX-10.1 a16-2714_2ex10d1.htm EX-10.1 18913
  Complete submission text file 0001104659-16-090881.txt   40508
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35268 | Film No.: 161354643
SIC: 2834 Pharmaceutical Preparations